Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 10,306 | 0.0% | 173,406 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 13,628 | 0.0% | 251,632 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 13,156 | 0.0% | 239,323 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 19,523 | 0.0% | 276,178 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 17,994 | 0.0% | 273,761 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 18,744 | 0.0% | 266,667 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 22,496 | 0.0% | 273,241 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 24,261 | 0.0% | 277,775 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 27,086 | 0.0% | 280,920 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 25,155 | 0.0% | 284,307 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 25,786 | 0.0% | 297,480 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 29,328 | 0.0% | 301,603 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 31,487 | 0.0% | 304,254 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 25,528 | 0.0% | 301,146 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 25,181 | 0.0% | 303,857 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 23,428 | 0.0% | 303,867 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 28,478 | 0.0% | 322,326 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 24,418 | 0.0% | 315,924 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 26,682 | 0.0% | 319,775 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 25,723 | 0.0% | 340,657 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 29,662 | 0.0% | 338,259 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 25,068 | 0.0% | 329,501 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 39,732 | 0.1% | 322,133 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 26,511 | 0.1% | 313,741 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 27,203 | 0.0% | 321,737 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 17,247 | 0.0% | 252,857 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 17,684 | 0.0% | 251,657 | 12/31/2013 |